The role of antipsychotic agents in the treatment of bipolar disorder patients

International Clinical Psychopharmacology

Volumn 12, Issue 2, 1997, Pages 65-76

  Soares, J C ^a   Mallinger, A G ^a   Gershon, S ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Antipsychotics; Bipolar disorder; Neuroleptics; Therapeutics; Treatment refractoriness

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM ANTAGONIST; CLOZAPINE; HALOPERIDOL; LITHIUM; NEUROLEPTIC AGENT; RISPERIDONE;

AGRANULOCYTOSIS; DEPRESSION; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DYSTONIA; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; NEUROTOXICITY; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RISK FACTOR; TARDIVE DYSKINESIA;

EID: 0030852618     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199703000-00001     Document Type: Review

References (140)

1. Ahlfors UG, Baastrup PC, Dencker SJ, Elgen K, Lingjaerde O, Pedersen V, Schou M and Aaskoven O (1981) Flupenthixol dccanoate in recurrent manic-depressive illness. Acta Psychiatrica Scandinava, 64, 226-237.
2. Akiskal HS (1996) The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. Journal of Clinical Psychopharmacology, 16 (Suppl 1), 4S-14S.
3. American Psychiatric Association (1994) Practice Guidelines for the Treatment of Patients with Bipolar Disorder. American Journal of Psychiatry, 151 (Suppl 12), 1-36.
4. Aronson TA, Shukla S and Hirschowitz J (1989) Clonazepam treatment of five lithium-refractory patients with bipolar disorder. American Journal of Psychiatry, 146, 77-80.
5. Baastrup PC, Hollnagel P, Sorensen R and Schou M (1976) Adverse reactions in treatment with lithium carbonate and haloperidol. JAMA, 236, 2645-2646.
6. Barton BM and Gitlin MJ (1987) Verapamil in treatment-resistant mania: an open trial. Journal of Clinical Psychopharmacology, 7, 101-103.
7. Bell AJ and Ferrier IN (1994) Lithium-induced neurotoxicity at therapeutic levels - an aetiological review. Lithium, 5, 181-186.
8. Berger JA, Eyland EA, Campbell JA, Jenkings P, Kellehear K, Richards A and Beumont PJ (1989) The course of tardive dyskinesia in patients on long-term neuroleptics. British Journal of Psychiatry, 154, 523-528.
9. Biederman J, Lerner Y and Belmaker RH (1979) Combination of lithium carbonate and haloperidol in schizo-affective disorder. Archives of General Psychiatry, 36, 327-333.
10. Bodkin JA (1990) Emerging uses for high-potency benzodiazepines in psychotic disorders. Journal of Clinical Psychiatry, 51 (Suppl 5), 41-46.
11. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG et al. (1994) Efficacy of divalproex versus lithium and placebo in the treatment of mania. JAMA, 271, 918-924.
12. Bowden CL (1995) Predictors of response to divalproex and lithium. Journal of Clinical Psychiatry, 56 (Suppl 3), 25-30.
13. Brady KT and Lydiard RB (1992) Bipolar affective disorder and substance abuse. Journal of Clinical Psychopharmacology, 12 (Suppl 1), 17S-22S.
14. Brockington IF, Kendell RE, Kellett JM, Curry SH and Wainwright S (1978) Trials of lithium, chlorpromazine and amitriptyline in schizoaffective patients. British Journal of Psychiatry, 133, 162-168.
15. Busch FN, Miller FT and Weiden PJ (1989) A comparison of two adjunctive treatment strategies in acute mania. Journal of Clinical Psychiatry, 50, 453-455.
16. Busto V, Sellers EM, Naranjo CA, Cappell HD, Sanchez-Craig M and Simpkins J (1986) Patterns of benzodiazepine abuse and dependence. British Journal of Addiction, 81, 87-94.
17. Calabrese JR, Bowden C and Woyshville MJ (1995) Lithium and the anticonvulsants in the treatment of bipolar disorder. In: Psychopharmacology: The Fourth Generation of Progress (Eds FE Bloom and DJ Kupfer DJ), pp. 1099-1112. Raven Press Ltd., New York.
18. Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA and Meltzer HY (1996) Clozapine for treatment-refractory mania. American Journal of Psychiatry, 153, 759-764.
19. Casey DE (1985) Tardive dyskinesia: reversible and irreversible. Psychopharmacology, 2 (Suppl), 88-97.
20. Cavallaro R, Regazzetti MG, Mundo E, Brancato V and Smeraldi E (1993) Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistence. Neuropsychopharmacology, 8, 233-239.
21. Chouinard G, Young SN and Annable L (1983) Antimanic effect of clonazepam. Biological Psychiatry, 18, 451-466.
22. Chouinard G (1988) The use of benzodiazepines in the treatment of manic-depressive illness. Journal of Clinical Psychiatry, 49 (Suppl 11), 15-19.
23. Chouinard G (1989) Clonazepam in treatment of bipolar psychotic patients after discontinuation of neuroleptics. American Journal of Psychiatry, 146, 1642.
24. Chouinard G (1995) Effects of risperidone in tardive dyskinesia: an analysis of the Canadian multicenter risperidone study. Journal of Clinical Psychopharmacology, 15 (Suppl 1), 36S-44S.
25. Cohen WJ and Cohen NH (1974) Lithium carbonate, haloperidol, and irreversible brain damage. JAMA, 230, 1283-1287.
26. Coxhead N, Silverstone T and Cookson J (1992) Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatrica Scandinava, 85, 114-118.
27. Dabiri LM, Pasta D, Darby JK and Mosbacher D (1994) Effectiveness of vitamin E for treatment of long-term tardive dyskinesia. American Journal of Psychiatry, 151, 925-926.
28. Dardennes R, Even C, Bange F and Heim A (1995) Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders - a meta-analysis. British Journal of Psychiatry, 166, 378-381.
29. Dilsaver SC, Swann AC, Shoaib AM, Bowers TC and Halle MT (1993) Depressive mania associated with nonresponse to antimanic agents. American Journal of Psychiatry, 150, 1548-1551.
30. Dinan TG and Kohen D (1989) Tardive dyskinesia and bipolar affective disorder: relationship to lithium therapy. British Journal of Psychiatry, 155, 55-57.
31. D'Mello DA and McNeil JA (1990) Sex differences in bipolar affective disorder: neuroleptic dosage variance. Comprehensive Psychiatry, 31, 80-83.
32. Dubovsky SL, Franks RD and Schrier D (1985) Phenelzine-induced hypomania: effect of verapamil. Biological Psychiatry, 20, 1009-1014.
33. Dubovsky SL, Franks RD, Allen S and Murphy J (1986) Calcium antagonists in mania: a double-blind study of verapamil. Psychiatry Research, 18, 309-320.
34. Dwight MM, Keck PE, Stanton SP, Strakowski SM and McElroy SL (1994) Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet, 344, 554-555.
35. Edwards R, Stephenson U and Flewett T (1991) Clonazepam in acute mania: a double blind trial. Australian and New Zealand Journal of Psychiatry, 25: 238-242.
36. Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, Blum A, Saenz RE and Wyatt RJ (1992) Treatment of tardive dyskinesia with vitamin E. American Journal of Psychiatry, 149, 773-777.
37. Emilien G, Maloteaux JM, Seghers A and Charles G (1996) Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis. European Neuropsychopharmacology, 6, 245-252.
38. Emrich HM, Dose M and von Zerssen D (1985) The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. Journal of Affective Disorders, 8, 243-250.
39. Esparon J, Kolloori J, Naylor GJ, McHarg AM, Smith AHW and Hopwood SE (1986) Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. British Journal of Psychiatry, 148, 723-725.
40. Feltner DE and Hertzman M (1993) Progress in the treatment of tardive dyskinesia: theory and practice. Hospital and Community Psychiatry, 44, 25-34.
41. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD and Swann AC (1992) A double-blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry, 149, 108-111.
42. Gardos G, Casey DE, Cole JO, Perenyi A, Kocsis E, Arato M, Samson JA and Conley C (1994) Ten-year outcome of tardive dyskinesia. American Journal of Psychiatry, 151, 836-841.
43. Garza-Trevino ES, Overall JE and Hollister LE (1992) Verapamil versus lithium in acute mania. American Journal of Psychiatry, 149, 121-122.
44. Gelenberg AJ (1995) Bipolar patients. Journal of Clinical Psychiatry (Monograph), 13, 28-29.
45. Gelenberg AJ and Hopkins HS (1996) Antipsychotics in bipolar disorder. Journal of Clinical Psychiatry, 57 (Suppl 9), 49-52.
46. Gershon S and Soares JC (1997) Commentary - current therapeutic profile of lithium. Archives of General Psychiatry, 54, 16-20.
47. Giannini AJ, Taraszewski R and Loiselle RH (1987) Verapamil and lithium in maintenance therapy of manic patients. Journal of Clinical Pharmacology, 27, 980-982.
48. Gitlin MJ and Weiss J (1984) Verapamil as maintenance treatment in bipolar illness: a case report. Journal of Clinical Psychopharmacology, 4, 341-343.
49. Glazer WM, Morgenstern H, Schooler N, Berkman CS and Moore DC (1990) Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication. British Journal of Psychiatry, 157, 585-592.
50. Glazer WM, Morgenstern H and Doucette JT (1991) The prediction of chronic persistent versus intermittent tardive dyskinesia. A retrospective follow-up study. British Journal of Psychiatry, 158, 822-828.
51. Goldberg JF, Harrow M and Grossman LS (1995) Recurrent affective syndromes in bipolar and unipolar mood disorders at follow-up. British Journal of Psychiatry, 166, 382-385.
52. Goldberg JF, Harrow M, Leon AC (1996) Lithium treatment of bipolar affective disorders under naturalistic follow-up conditions. Psychopharmacology Bulletin, 32, 47-54.
53. Goldman SA (1996) Lithium and neuroleptics in combination: is there enhancement of neurotoxicity leading to permanent sequelae? Journal of Clinical Pharmacology, 36, 951-962.
54. Goldney RD and Spence ND (1986) Safety of the combination of lithium and neuroleptic drugs. American Journal of Psychiatry, 143, 882-884.
55. Goodwin FK and Zis AP (1979) Lithium in the treatment of mania: comparisons with neuroleptics. Archives of General Psychiatry, 36, 840-844.
56. Goodnick PJ (1995) Risperidone treatment of refractory acute mania Journal of Clinical Psychiatry, 56, 431-432.
57. Gouliaev G, Licht RW, Vestergaard P, Merinder L, Lund H and Bjerre L (1996) Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatrica Scandinavica, 93, 119-124.
58. Guscott R and Taylor L (1994) Lithium prophylaxis in recurrent affective illness. Efficacy, effectiveness and efficiency. British Journal of Psychiatry, 164, 741-746.
59. Hardy MC, Lecrubier Y and Widlocher D (1986) Efficacy of clonidine in 24 patients with acute mania. American Journal of Psychiatry, 143, 1450-1453.
60. Hendrick V, Altshuler LL and Szuba MP (1994) Is there a role for neuroleptics in bipolar disorder? Journal of Clinical Psychiatry, 55, 533-535.
61. Hunt N and Silverstone T (1991) Tardive dyskinesia in bipolar affective disorder: a catchment area study. International Clinical Psychopharmacology, 6, 45-50.
62. Jeste DV and Caligiuri MP (1993) Tardive dyskinesia. Schizophrenia Bulletin, 19, 303-315.
63. Johnson G, Gershon S, Burdock EI, Floyd A and Hekimian L (1971) Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. British Journal of Psychiatry, 119, 267-276.
64. Jouvent R, Lecrubier Y, Puech AJ, Simon P and Widlocher D (1980) Antimanic effect of clonidine. American Journal of Psychiatry, 137, 1275-1276.
65. Kanter GL, Yerevanian BI and Ciccone JR (1984) Case report of a possible interaction between neuroleptics and carbamazepine. American Journal of Psychiatry, 141, 1101-1102.
66. Keck PE Jr, McElroy SL, Tugrul KC and Bennett JA (1993) Valproate oral loading in the treatment of acute mania. Journal of Clinical Psychiatry, 54, 305-308.
67. Keck PE Jr and McElroy SL (1996) Outcome in the pharmacologic treatment of bipolar disorder. Journal of Clinical Psychopharmacology, 16 (Suppl 1), 15S-23S.
68. Keck PE Jr, McElroy SL, Strakowski SM, Balistreri TM, Kizer DL and West SA (1996) Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder. Journal of Clinical Psychiatry, 57, 147-151.
69. Kerwin RW (1994) The new atypical antipsychotics - a lack of extrapyramidal side-effects and new routes in schizophrenia research. British Journal of Psychiatry, 164, 141-148.
70. Kessel JB, Verghese C and Simpson GM (1992) Neurotoxicity related to lithium and neuroleptic combinations? A retrospective review. Journal of Psychiatry and Neurosciences, 17, 28-30.
71. Kramlinger KG and Post RM (1989a) Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment-resistant mania. Acta Psychiatrica Scandinavica, 79, 378-385.
72. Kramlinger KG and Post RM (1989b) The addition of lithium to carbamazepine: antidepressant efficacy in treatment-resistant depression. Archives of General Psychiatry, 46, 794-800.
73. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G and Tondo L (1980) Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatrie-Neuropsychopharmakol, 13, 156-167.
74. Lenox RH, Newhouse PA, Creelman WL and Whitaker TM ( 1992) Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. Journal of Clinical Psychiatry, 53, 47-52.
75. Licht RW, Gouliaev G, Vestergaard P, Dybbro J, Lund H and Merinder L (1994) Treatment of manic episodes in Scandinavia: the use of neuroleptic drugs in a clinical routine setting. Journal of Affective Disorders, 32, 179-185.
76. Lieberman J, Johns C, Cooper T, Pollack S and Kane J (1989) Clozapine pharmacology and tardive dyskinesia. Psychophamacology, 99 (Suppl), S54-S59.
77. Littlejohn R, Leslie F and Cookson J (1994) Depot antipsychotics in the prophylaxis of bipolar affective disorder. British Journal of Psychiatry, 165, 827-829.
78. Lusznat RM, Murphy DP and Nunn CMH (1988) Carbamazepine vs lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry, 153, 198-204.
79. Maguire J (1987) Clonidine - an effective anti-manic agent? British Journal of Psychiatry, 150, 863-864.
80. McElroy SL, Keck PE Jr, Pope HG Jr and Hudson JI (1992) Valproate in the treatment of bipolar disorder: literature review and clinical guidelines. Journal of Clinical Psychopharmacology, 12, 42S-52S.
81. McElroy SL, Keck PE, Stanton SR Tugrul KC, Bennett JA and Strakowski SM (1996) A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. Journal of Clinical Psychiatry, 57, 142-146.
82. Meltzer HY and Luchins DJ (1984) Effect of clozapine in severe tardive dyskinesia: a case report. Journal of Clinical Psychopharmacology, 4, 286-287.
83. Miller F, Menninger J and Whitcup SM (1986) Lithium-neuroleptic neurotoxicity in the elderly bipolar patient. Journal of Clinical Psychopharmacology, 6, 176-178.
84. Miller F and Menninger J (1987a) Lithium-neuroleptic neurotoxicity is dose dependent. Journal of Clinical Psychopharmacology, 72, 89-91.
85. Miller F and Menninger J (1987b) Correlation of neuroleptic dose and neurotoxicity in patients given lithium and a neuroleptic. Hospital and Community Psychiatry, 38, 1219-1221.
86. Miller NS and Gold MS (1991) Abuse, addiction, tolerance, and dependence to benzodiazepines in medical and non-medical populations. American Journal of Drug and Alcohol Abuse, 17, 27-37.
87. Miller CH, Simioni I, Oberbauer H, Schwitzer J, Barnas C, Kulhanek F, Boissel KE, Meise U, Hinterhuber H and Fleischhacker W (1995) Tardive dyskinesia prevalence rates during a ten-year follow-up. The Journal of Nervous and Mental Disease, 183, 404-407.
88. Modell JG, Lenox RH and Weiner S (1985) Inpatient clinical trial of lorazepam for the management of manic agitation. Journal of Clinical Psychopharmacology, 5, 109-113.
89. Morgenstern H and Glazer WM (1993) Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. Archives of General Psychiatry, 50, 723-733.
90. Mukherjee S, Rosen AM, Carracci G and Shukla S (1986) Persistent tardive dyskinesia in bipolar patients. Archives of General Psychiatry, 43, 342-346.
91. Nasrallah HA, Churchill CM and Hamdan-Allan GA (1988) Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. American Journal of Psychiatry, 145, 1455-1456.
92. Okuma T, Inanaga K, Otsuki S, Sarai K, Takahashi R, Hazama H, Mori A and Watanabe M (1979) Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study. Psychopharmacology, 66, 211-217.
93. Parker G, Roy K, Hadzi-Pavlovic D and Pedic F (1992) Psychotic (delusional) depression: a meta-analysis of physical treatments. Journal of Affective Disorders, 24, 17-24.
94. Perenyi A, Szucs R and Frecska E (1984) Tardive dyskinesia in patients receiving lithium maintenance therapy. Biological Psychiatry, 19, 1573-1578.
95. Peselow ED, Fieve RR, Difiglia C and Sanfilipo MP (1994) Lithium prophylaxis of bipolar illness -the value of combination treatment. British Journal of Psychiatry, 164, 208-214.
96. Platman SR (1970) A comparison of lithium carbonate and chlorpromazine in mania. American Journal of Psychiatry, 127, 351-353.
97. Pope HG, McElroy SL, Keck PE Jr and Hudson JI (1991) Valproate in the treatment of acute mania. Archives of General Psychiatry, 48, 62-68.
98. Post RM, Uhde TW, Roy-Byrne PP and Joffe RT (1987) Correlates of antimanic response to carbamazepine. Psychiatry Research, 21, 71-83.
99. Price LH and Henninger GR (1994) Lithium in the treatment of mood disorders. New England Journal of Medicine, 331, 591-598.
100. Prien RF, Caffey EM Jr and Klett CJ (1972) A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives - Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry, 27, 182-189.
101. Prien RF and Gelenberg AJ (1989) Alternatives to lithium for preventive treatment of bipolar disorder. American Journal of Psychiatry, 146, 840-848.
102. Prien RF and Potter WZ (1990) NIMH Workshop report on treatment of bipolar disorder. Psychopharmacology Bulletin, 26, 409-427.
103. Prien RF and Rush AJ (1996) National Institute of Mental Health workshop report on the treatment of bipolar disorder. Biological Psychiatry, 40, 215-220.
104. Remington GJ. Voineskos G, Pollock B, Reed K and Coulter K (1990) Prevalence of neuroleptic-induced dystonia in mania and schizophrenia. American Journal of Psychiatry, 147, 1231-1233.
105. Rothschild AJ, Samson JA, Bessette MP and Carter-Campbell JT (1993) Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. Journal of Clinical Psychiatry, 54, 338-342.
106. Sachs GS (1990) Use of clonazepam for bipolar affective disorder. Journal of Clinical Psychiatry, 51 (Suppl 5), 31-34.
107. Sachs GS, Weilburg JB and Rosenbaum JF (1990a) Clonazepam versus neuroleptics as adjuncts to lithium maintenance. Psychopharmacology Bulletin, 26, 137-143.
108. Sachs GS, Rosenbaum JF and Jones L (1990b) Adjunctive clonazepam for maintenance treatment of bipolar affective disorder. Journal of Clinical Psychopharmacology, 10, 42-47.
109. Sachs GS (1996) Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. Journal of Clinical Psychopharmacology, 16 (Suppl 1), 32S-47S.
110. Sajatovic M, DiGiovanni SK, Bastani B, Hattab H and Ramirez LF (1996) Risperidone therapy in treatment refractory acute bipolar and schizoaffective mania. Psychopharmacology Bulletin, 32, 55-61.
111. Sandyk R, Kay SR, Awerbuch GI and Iacono RP (1991) Risk factors for neuroleptic-induced movement disorders. International Journal of Neuroscience, 61, 149-188.
112. Saran A, Addy O, Foliart RH, Schubert DS and Halaris A (1989) Electroencephalographic changes and other indices of neurotoxicity with haloperidol-lithium therapy. Neuropsychobiology, 20, 152-157.
113. Schaffer CB and Schaffer LC (1996) The use of risperidone in the treatment of bipolar disorder. Journal of Clinical Psychiatry, 57, 136.
114. Sernyak MJ and Woods SW (1993) Chronic neuroleptic use in manic-depressive illness. Psychopharmacology Bulletin, 29, 375-381.
115. Sernyak MJ, Griffin RA, Johnson RM, Pearsall HR, Wexler BE and Woods SW (1994) Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. American Journal of Psychiatry, 151, 133-135.
116. Shopsin B, Gershon S, Thompson H and Collins P (1975) Psychoactive drugs in mania. Archives of General Psychiatry, 32, 34-42.
117. Shukla S, Cook BL and Miller MG (1985) Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness. Journal of Affective Disorders, 9, 219-222.
118. Small JG, Milstein V, Marhenke JD, Hall DD and Kellams JJ (1987) Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis. Journal of Clinical Psychiatry, 48, 263-267.
119. Sonne SC, Brady KT and Morton WA (1994) Substance abuse and bipolar affective disorder. Journal of Nervous and Mental Disease, 182, 349-352.
120. Spiker DG, Weiss JC, Dealy RS, Griffin SJ, Hanin I, Neil JF, Perel JM, Rossi AJ and Soloff PH (1985) The pharmacological treatment of delusional depression. American Journal of Psychiatry, 142, 430-436.
121. Spring G, Schweid D, Gray C, Steinberg J and Horwitz M (1970) A double-blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry, 126, 1306-1310.
122. Steiner W, Laporta M and Chouinard G (1990) Neuroleptic-induced supersensitivity psychosis in patients with bipolar affective disorder. Acta Psychiatrica Scandinava, 81, 437-440.
123. Strakowski SM, Tohen M, Stoll AL, Faedda GL and Goodwin DC (1992) Comorbidity in mania at first hospitalization. American Journal of Psychiatry, 149, 554-556.
124. Suppes T McElroy SL, Gilbert J, Dessain EC and Cole JO (1992) Clozapine in the treatment of dysphoric mania. Biological Psychiatry, 32, 270-280.
125. Suppes T, Phillips KA and Judd CR (1994) Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases. Biological Psychiatry 36, 338-340.
126. Takahashi R, Sakuma A, Itoh K, Itoh H and Kurihara M (1975) Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Report of collaborative study group on treatment of mania in Japan. Archives of General Psychiatry, 32, 1310-1318.
127. Tohen M, Castillo J and Pope HG (1994) Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders. Journal of Clinical Psychopharmacology, 14, 67-70.
128. Victor BS, Link NA, Binder RL and Bell IR (1984) Use of clonazepam in mania and schizoaffective disorders. American Journal of Psychiatry, 141, 1111-1112.
129. Waddington JL and Youssef HA (1988) Tardive dyskinesia in bipolar affective disorder: aging, cognitive dysfunction, course of illness, and exposure to neuroleptics and lithium. American Journal of Psychiatry, 145, 613-616.
130. Waddington JL, Brown K, O'Neill J, McKeon P and Kinsella A (1989) Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: relationship with tardive dyskinesia. Psychological Medicine, 19, 897-902.
131. Wade JB, Taylor MA, Kasprisin A, Rosemberg S and Fiducia D (1987) Tardive dyskinesia and cognitive impairment. Biological Psychiatry, 22, 393-395.
132. Wegner JT and Kane JM (1982) Follow-up study on the reversibility of tardive dyskinesia. American Journal of Psychiatry, 139, 368-369.
133. White E, Cheung P and Silverstone T (1993) Depot antipsychotics in bipolar affective disorder. International Clinical Psychopharmacology, 8, 119-122.
134. Winokur G, Coryell W, Akiskal HS, Endicott J, Keller M and Mueller T (1994) Manic-depressive (bipolar) disorder: the course in light of a prospective ten-year follow-up of 131 patients. Acta Psychiatrica Scandinavica, 89, 102-110.
135. Wright BA and Jarrett DB (1991) Lithium and calcium channel blockers: possible neurotoxicity. Biological Psychiatry, 30, 635-636.
136. Yassa R, Nair V and Schwartz G (1984) Tardive dyskinesia and the primary psychiatric diagnosis. Psychosomatics, 25, 135-138.
137. Youssef HA and Waddington JL (1988) Primitive (developmental) reflexes and diffuse cerebral dysfunction in schizophrenia and bipolar affective disorder: overrepresentation in patients with tardive dyskinesia. Biological Psychiatry, 23, 791-796.
138. Zarate CA Jr, Tohen M and Baldessarini RJ (1995a) Clozapine in severe mood disorders. Journal of Clinical Psychiatry, 56, 411-417.
139. Zarate CA Jr, Tohen M, Banov MD, Weiss MK and Cole JO (1995b) Is clozapine a mood stabilizer? Journal of Clinical Psychiatry, 56, 108-112.
140. Zubenko GS, Cohen BM, Lipinski JF and Jonas JM (1984) Clonidine in the treatment of mania and mixed bipolar disorder, American Journal of Psychiatry, 141, 1617-1618.